| Date | Title | Description |
| 12.02.2026 | Navamedic ASA: Strong growth and important product launch in Q4 2025 | Navamedic ASA: Strong growth and important product launch in Q4 2025
Thu, Feb 12, 2026 07:00 CET Report this content
Oslo, 12 February 2026 - In the fourth quarter of 2025, Navamedic ASA achieved its highest quarterly revenue ever at NOK 15... |
| 29.12.2025 | Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg | Grete Roede og Navamedic lanserer nytt vektreduksjonskonsept: Lettere steg
Mon, Dec 29, 2025 08:23 CET Report this content
Grete Roede og Navamedic inngår et samarbeid om en ny, strukturert metode for vektreduksjon. Det første konseptet, Le... |
| 09.12.2025 | Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment | Oslo, December 9, 2025 - Navamedic ASA Introduces Flexilev[®] in OraFID[®]: Enhancing Parkinson's Care with Simplified and Precise Dosing for Personalized Treatment
Tue, Dec 09, 2025 13:00 CET Report this content
Navamedic ASA is excited to... |
| 03.12.2025 | Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt | Ny svensk Novusundersökning: Så vanligt är känslomässigt ätande vid övervikt
Wed, Dec 03, 2025 13:32 CET Report this content
Stockholm, Sverige – [2025.12.03] – Är du en känsloätare? Då är du inte ensam. En ny Novusundersökning visar att dr... |
| 28.10.2025 | Navamedic ASA: Double digit growth in the 3rd quarter, 2025 | Navamedic ASA: Double digit growth in the 3rd quarter, 2025
Tue, Oct 28, 2025 07:00 CET Report this content
Oslo, October 28th, 2025 – In the third quarter 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of hig... |
| 24.10.2025 | Navamedic ASA: Invitation to 2025 3rd quarter presentation | Navamedic ASA: Invitation to 2025 3rd quarter presentation
Fri, Oct 24, 2025 17:56 CET Report this content
Oslo, October 24, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 3rd quarter 2025 results on Tuesday, October 28th, 2025. Th... |
| 17.10.2025 | Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical | Navamedic ASA: Navamedic extends its business into Germany together with Evolsin Medical
Fri, Oct 17, 2025 11:21 CET Report this content
Norwegian pharma company Navamedic and German pharma company Evolsin Medical, have signed an exclusive ... |
| 13.10.2025 | Observe Medical ASA: Disclosure of major shareholdings following completion of the Private Placement and Subsequent Offering | Observe Medical ASA: Disclosure of major shareholdings following completion of the Private Placement and Subsequent Offering
Mon, Oct 13, 2025 21:00 CET Report this content
Reference is made to the stock exchange announcements published by ... |
| 13.10.2025 | Navamedic ASA – New share capital registered | Navamedic ASA – New share capital registered
Mon, Oct 13, 2025 18:25 CET Report this content
Oslo, 13 October 2024: Reference is made to the stock exchange announcement published by Navamedic ASA (the "Company") on 7 October 2025,... |
| 07.10.2025 | Navamedic ASA: Final results of the rights issue | Navamedic ASA: Final results of the rights issue
Tue, Oct 07, 2025 12:42 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE ... |
| 07.10.2025 | Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates | Navamedic ASA: Allocation of shares in the rights issue to primary insiders and their close associates
Tue, Oct 07, 2025 12:55 CET Report this content
Oslo, 7 October 2025: Reference is made to the stock exchange announcement published by N... |
| 06.10.2025 | Navamedic ASA: Preliminary results of the rights issue | Navamedic ASA: Preliminary results of the rights issue
Mon, Oct 06, 2025 20:47 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTR... |
| 06.10.2025 | Navamedic ASA: Last day of the subscription period in the rights issue | Navamedic ASA: Last day of the subscription period in the rights issue
Mon, Oct 06, 2025 08:00 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG S... |
| 30.09.2025 | Navamedic ASA: Last day of trading in subscription rights | Navamedic ASA: Last day of trading in subscription rights
Tue, Sep 30, 2025 08:00 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINI... |
| 22.09.2025 | Navamedic ASA: Commencement of the subscription period for the rights issue | Navamedic ASA: Commencement of the subscription period for the rights issue
Mon, Sep 22, 2025 07:30 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG K... |
| 22.09.2025 | Navamedic ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates | Navamedic ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates
Mon, Sep 22, 2025 21:26 CET Report this content
Oslo, 22 September 2025: Reference is made to the stock exchange announcement p... |
| 19.09.2025 | Navamedic ASA: Approval and publication of prospectus | Navamedic ASA: Approval and publication of prospectus
Fri, Sep 19, 2025 11:05 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRA... |
| 01.09.2025 | Navamedic ASA: Updated key information relating to the rights issue | Navamedic ASA: Updated key information relating to the rights issue
Mon, Sep 01, 2025 12:45 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPEC... |
| 14.08.2025 | Navamedic ASA: Financial report for the 2nd quarter and first half of 2025 | Navamedic ASA: Financial report for the 2nd quarter and first half of 2025
Thu, Aug 14, 2025 07:00 CET Report this content
Oslo, 14 August 2025 – In the first half of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supp... |
| 13.08.2025 | Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries. | Navamedic ASA: National approvals of Flexilev® in OraFID® granted across all Nordic countries.
Wed, Aug 13, 2025 09:51 CET Report this content
Oslo, Norway – 2025.08.13 – Navamedic is pleased to announce that it has received final approval ... |
| 11.08.2025 | Navamedic ASA: Invitation to 2025 2nd quarter presentation | Navamedic ASA: Invitation to 2025 2nd quarter presentation
Mon, Aug 11, 2025 13:03 CET Report this content
Oslo, August 11, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 2nd quarter/1st half 2025 results on Thursday, August 14, 20... |
| 15.07.2025 | Navamedic ASA: Closing of the transaction to acquire the business of dne pharma | Navamedic ASA: Closing of the transaction to acquire the business of dne pharma
Tue, Jul 15, 2025 12:32 CET Report this content
Oslo, 15 July 2025: Reference is made to the stock exchange announcement published by Navamedic ASA ("Navam... |
| 14.07.2025 | Navamedic ASA - Minutes of Extraordinary General Meeting | Navamedic ASA - Minutes of Extraordinary General Meeting
Mon, Jul 14, 2025 15:27 CET Report this content
Oslo, July 14, 2025. The announced Extraordinary General Meeting of Navamedic ASA was held today at 13.00 CET. All items on the agenda ... |
| 09.07.2025 | Observe Medical ASA: Registration of new share capital | Observe Medical ASA: Registration of new share capital
Wed, Jul 09, 2025 10:38 CET Report this content
Oslo, 9 July
Reference is made to the announcement by Observe Medical ASA (the "Company" or "Observe Medical", OSE ti... |
| 29.06.2025 | Navamedic ASA: Pioneering Precision in Pharmaceutical Delivery | In the world of pharmaceuticals, precision is paramount. Navamedic ASA, a Nordic pharmaceutical company, is making waves with its innovative medical device, OraFID®. Recently approved by the Swedish Medical Products Agency, this device repr... |
| 29.06.2025 | Navamedic ASA – Additional underwriting commitments in the Rights Issue | Navamedic ASA – Additional underwriting commitments in the Rights Issue
Sun, Jun 29, 2025 13:36 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG ... |
| 27.06.2025 | Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product | Navamedic ASA: First approval of the medical device OraFID® as primary package for a pharmaceutical product
Fri, Jun 27, 2025 14:14 CET Report this content
Oslo, Norway - 2025.06.27 - Navamedic announces that the Swedish Medical Products Ag... |
| 24.06.2025 | Navamedic ASA's Bold Step into Addiction Treatment: A Strategic Acquisition | In a significant move, Navamedic ASA has set its sights on the burgeoning field of addiction treatment. The Oslo-based pharmaceutical company announced its acquisition of dne pharma, a Norwegian firm specializing in addiction therapies, for... |
| 24.06.2025 | Navamedic ASA: A Strategic Move Towards Growth Through Rights Issue | In the fast-paced world of healthcare, companies must adapt and evolve. Navamedic ASA, a prominent player in the Nordic pharmaceutical market, is taking a bold step forward. On June 23, 2025, the company announced plans for an extraordinary... |
| 24.06.2025 | Navamedic ASA – Investor presentation regarding the acquisition of the business of dne pharma AS | Navamedic ASA – Investor presentation regarding the acquisition of the business of dne pharma AS
Tue, Jun 24, 2025 08:00 CET Report this content
Reference is made to the announcement made by Navamedic ASA (the "Company" or "N... |
| 23.06.2025 | Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue | Navamedic ASA expands into addiction treatment through the acquisition of the business of dne pharma and announces a partially underwritten rights issue
Mon, Jun 23, 2025 08:00 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECT... |
| 23.06.2025 | Navamedic ASA: Key information relating to the Rights Issue | Navamedic ASA: Key information relating to the Rights Issue
Mon, Jun 23, 2025 08:15 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMI... |
| 23.06.2025 | Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue | Navamedic ASA: Notice of extraordinary general meeting on 14 July 2025 in connection with a contemplated rights issue
Mon, Jun 23, 2025 12:45 CET Report this content
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UN... |
| 04.06.2025 | Navamedic ASA: Minutes of Annual General Meeting | Navamedic ASA: Minutes of Annual General Meeting
Wed, Jun 04, 2025 10:29 CET Report this content
Oslo, 4 June 2025: The Annual General Meeting of Navamedic ASA was held today at 09:00 CEST. All items on the agenda were resolved in accordanc... |
| 14.05.2025 | Navamedic ASA: Notice of Annual General Meeting | Navamedic ASA: Notice of Annual General Meeting
Wed, May 14, 2025 14:35 CET Report this content
The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Wednesday, June 4th 2025 at 09:00 (CET) in the Navamedic offices in Henr... |
| 05.05.2025 | Navamedic ASA launches Eroxon® in Denmark | Navamedic ASA launches Eroxon® in Denmark
Mon, May 05, 2025 10:56 CET Report this content
Oslo, 05 May 2025 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and trusted supplier of high-quality prescription, consumer health, and hospita... |
| 30.04.2025 | Navamedic ASA: Annual Report 2024 | Navamedic ASA: Annual Report 2024
Wed, Apr 30, 2025 19:42 CET Report this content
Oslo, April 30 2025 - Navamedic ASA has today published its Annual Report for 2024. Find enclosed the report in PDF as well as an ESEF file version. The repor... |
| 30.04.2025 | Navamedic Q1 2025: Strong start of the year and well-positioned for future growth | Navamedic Q1 2025: Strong start of the year and well-positioned for future growth
Wed, Apr 30, 2025 07:00 CET Report this content
Oslo, 30 April 2025 – In the first quarter of 2025, Navamedic ASA (OSE: NAVA), a Nordic pharma company and tru... |
| 29.04.2025 | Navamedic ASA: Imdur® distribution agreement extended to 2032 | Navamedic ASA: Imdur® distribution agreement extended to 2032
Tue, Apr 29, 2025 17:35 CET Report this content
Oslo, 29 April 2025 – Navamedic ASA (OSE: NAVA) today announced it has signed a renewed distribution agreement with TopRidge Pharm... |
| 28.04.2025 | Navamedic ASA: Invitation to 2025 1st quarter presentation | Navamedic ASA: Invitation to 2025 1st quarter presentation
Mon, Apr 28, 2025 12:06 CET Report this content
Oslo, April 28, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2025 results on Wednesday, April 30, 2025. The pr... |
| 13.04.2025 | Observe Medical: Navigating Financial Waters with Strategic Moves | In the world of medtech, the stakes are high. Companies must innovate while managing financial health. Observe Medical, a Nordic player in this arena, is currently making headlines for its bold moves to reduce debt and secure new equity. Th... |
| 10.04.2025 | Observe Medical has entered into agreements in principle with major creditors for a 50% debt reduction | Observe Medical has entered into agreements in principle with major creditors for a 50% debt reduction
Thu, Apr 10, 2025 08:50 CET Report this content
Oslo, April 10th, 2025 – Observe Medical ("the Company" or "Observe Medica... |
| 01.04.2025 | Navamedic Welcomes CHMP's Positive Review of Mysimba’s Cardiovascular Safety | Navamedic Welcomes CHMP's Positive Review of Mysimba’s Cardiovascular Safety
Tue, Apr 01, 2025 15:00 CET Report this content
Oslo, Norway – [2025.04.01] – Navamedic is pleased to announce that the European Medicines Agency’s (EMA) human med... |
| 12.02.2025 | Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives | Navamedic Q4 and Full Year 2024: Continued growth in a year with investments in new growth initiatives
Wed, Feb 12, 2025 07:00 CET Report this content
Oslo, 12 February 2025 – For the full year 2024, Navamedic ASA (OSE: NAVA), a Nordic phar... |
| 10.02.2025 | Navamedic ASA: Invitation to 2024 4th quarter presentation | Navamedic ASA: Invitation to 2024 4th quarter presentation
Mon, Feb 10, 2025 11:00 CET Report this content
Oslo, February 10, 2025 - Navamedic ASA (OSE: Nava) will be presenting its 4th quarter 2024 results on Wednesday, February 12, 2025. ... |
| 16.11.2024 | Financial Restructuring: A New Chapter for Navamedic and Observe Medical | In the world of finance, the winds of change often blow unexpectedly. Recently, two Nordic companies, Navamedic ASA and Observe Medical ASA, found themselves navigating these shifting currents. On November 15, 2024, both companies announced... |
| 15.11.2024 | Navamedic ASA: Amendments to loan agreements with Observe Medical ASA | Navamedic ASA: Amendments to loan agreements with Observe Medical ASA
Fri, Nov 15, 2024 13:00 CET Report this content
Oslo, November 15, 2024. Navamedic has two loans to Observe Medical ASA, Loan 1 from 27 September 2019, where the current ... |
| 06.11.2024 | Navamedic launches Eroxon[®] in Finland | Navamedic launches Eroxon[®] in Finland
Wed, Nov 06, 2024 09:10 CET Report this content
Oslo, 6 November 2024 – Building on the successful product launch of Eroxon® in Norway and Sweden earlier this year, Navamedic ASA (OSE: NAVA), a Nordic... |
| 06.11.2024 | Navamedic ASA: Mandatory notice of trade | Navamedic ASA: Mandatory notice of trade
Wed, Nov 06, 2024 13:52 CET Report this content
Oslo, November 6, 2024: Lars Hjarrand, CFO and a primary insider of Navamedic ASA, has today bought 20.000 Navamedic ASA shares at an average price of ... |
| 01.11.2024 | Navamedic's Q3 2024: Navigating Challenges with Resilience | In the world of pharmaceuticals, the tides can shift quickly. Navamedic ASA, a Nordic pharmaceutical company, recently released its third-quarter results for 2024. The numbers tell a story of resilience amid cyclical challenges. For the qua... |
| 31.10.2024 | Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business | Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business
Thu, Oct 31, 2024 07:00 CET Report this content
Oslo, 31 October 2024 – In the third quarter of 2024, Navamedic ASA (OSE: NAVA), a Nordic phar... |
| 28.10.2024 | Navamedic ASA: Invitation to 2024 3rd quarter presentation | Navamedic ASA: Invitation to 2024 3rd quarter presentation
Mon, Oct 28, 2024 09:08 CET Report this content
Oslo, October 28, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 3rd quarter 2024 results on Thursday, October 31st, 2024. T... |
| 07.10.2024 | Navamedic wins joint Nordic antibiotics tender | Navamedic wins joint Nordic antibiotics tender
Mon, Oct 07, 2024 13:56 CET Report this content
Oslo, 07 October 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharma... |
| 15.09.2024 | A Digital Lifeline: Alex Therapeutics and Navamedic Unite for Parkinson’s Care | In a world where technology meets healthcare, a new partnership is emerging. Alex Therapeutics and Navamedic have joined forces to develop a Companion App aimed at transforming the treatment landscape for Parkinson’s disease. This collabora... |
| 12.09.2024 | Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson’s Disease | Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson’s Disease
Thu, Sep 12, 2024 12:00 CET Report this content
Stockholm Sweden, September 12, 2024 - ... |
| 12.09.2024 | Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease | Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease
Thu, Sep 12, 2024 12:00 CET Report this content
Stockholm Sweden, September 12, 2024 - N... |
| 10.09.2024 | Navamedic ASA: A Strategic Move in Share Capital Expansion | On September 9, 2024, Navamedic ASA made headlines with a significant decision to increase its share capital. This move, rooted in the exercise of employee options, signals a strategic pivot for the company. The board of directors approved ... |
| 09.09.2024 | NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS | NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
Mon, Sep 09, 2024 16:03 CET Report this content
Oslo, 9 September 2024: The board of directors of Navamedic ASA (the "Company"... |
| 09.09.2024 | Navamedic ASA – Mandatory notification of trade by primary insider | Navamedic ASA – Mandatory notification of trade by primary insider
Mon, Sep 09, 2024 16:47 CET Report this content
Oslo, 9 September 2024: Reference is made to the stock exchange announcement published earlier today, on 9 September 2024 by ... |
| 16.08.2024 | Navamedic's Steady Ascent: A Look at Q2 and H1 2024 Performance | In the world of pharmaceuticals, stability is a rare gem. Navamedic ASA, a Nordic pharmaceutical company, has polished this gem through its recent performance in the first half of 2024. The company reported revenues of NOK 277.2 million, ma... |
| 16.08.2024 | Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement | Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement
Fri, Aug 16, 2024 07:00 CET Report this content
Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pha... |
| 12.08.2024 | Navamedic ASA: Invitation to 2024 2nd quarter presentation | Navamedic ASA: Invitation to 2024 2nd quarter presentation
Mon, Aug 12, 2024 10:00 CET Report this content
Oslo, August 12, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 2nd quarter/1st half 2024 results on Friday, August 16, 2024... |
| 24.06.2024 | Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe | Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe
Mon, Jun 24, 2024 16:19 CET Report this content
Oslo, 24 June 2024 - Navamedic ASA and Orion Corporation (“Orion”) have today signed a license and s... |
| 04.06.2024 | Navamedic ASA: Minutes of Annual General Meeting | Navamedic ASA: Minutes of Annual General Meeting
Tue, Jun 04, 2024 10:18 CET Report this content
Oslo, 4 June 2024: The Annual General Meeting of Navamedic ASA was held today at 09:00 CEST. All items on the agenda were resolved in accordanc... |
| 16.05.2024 | Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals | Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals
Thu, May 16, 2024 09:00 CET Report this content
Oslo, 16 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality p... |
| 14.05.2024 | Navamedic ASA: Notice of Annual General Meeting | Navamedic ASA: Notice of Annual General Meeting
Tue, May 14, 2024 14:10 CET Report this content
The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Tuesday, June 4th 2024 at 09:00 (CET) in the Navamedic offices in Henrik... |
| 06.05.2024 | Navamedic ASA: Broad launch for Eroxon® in Sweden today | Navamedic ASA: Broad launch for Eroxon® in Sweden today
Mon, May 06, 2024 11:00 CET Report this content
Oslo, 6 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and ph... |
| 30.04.2024 | Navamedic Q1 2024: Successful product launch and steady operational progress | Navamedic Q1 2024: Successful product launch and steady operational progress
Tue, Apr 30, 2024 07:00 CET Report this content
Oslo, 30 April 2024 – In the first quarter 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable pr... |
| 30.04.2024 | Navamedic ASA: Annual Report 2023 | Navamedic ASA: Annual Report 2023
Tue, Apr 30, 2024 17:45 CET Report this content
Oslo, 30 April 30 2024 - Navamedic ASA has today published its Annual Report for 2023 approved by the Board of Directors. Find enclosed the report in PDF as w... |
| 23.04.2024 | Navamedic ASA: Invitation to 2024 1st quarter presentation | Navamedic ASA: Invitation to 2024 1st quarter presentation
Tue, Apr 23, 2024 14:30 CET Report this content
Oslo, April 23, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The pres... |
| 15.03.2024 | Navamedic ASA – Mandatory notification of trade by primary insider | Navamedic ASA – Mandatory notification of trade by primary insider
Fri, Mar 15, 2024 13:30 CET Report this content
Oslo, 15 March 2024: Reference is made to the stock exchange announcement published earlier today, on 15 March 2024 by Navame... |
| 15.03.2024 | Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options | Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options
Fri, Mar 15, 2024 11:51 CET Report this content
Oslo, 15 March 2024: The board of directors of Navamedic ASA (the "Company"), ... |
| 30.08.2023 | Navamedic ASA – Registration of share capital increase | Navamedic ASA – Registration of share capital increase
Wed, Aug 30, 2023 13:02 CET Report this content
Oslo, 30 August 2023: Reference is made to the stock exchange announcement published on 18 August 2023 by Navamedic ASA (the "Compan... |
| 07.08.2023 | Navamedic ASA: Invitation to 2023 2nd quarter presentation | Navamedic ASA: Invitation to 2023 2nd quarter presentation
Mon, Aug 07, 2023 12:24 CET Report this content
Oslo, August 7, 2023 - Navamedic ASA (OSE: Nava) will be presenting its second quarter 2023 results and publish its first half 2023 r... |
| 01.06.2023 | Navamedic ASA: Minutes of Annual General Meeting | Navamedic ASA: Minutes of Annual General Meeting
Thu, Jun 01, 2023 11:35 CET Report this content
Oslo, 1 June 2023: The Annual General Meeting of Navamedic ASA was held today at 10:00 CEST. All items on the agenda were resolved in accordanc... |
| 31.05.2023 | Updated recommendation by the nomination committee of Navamedic ASA | Updated recommendation by the nomination committee of Navamedic ASA
Wed, May 31, 2023 14:16 CET Report this content
Following Navamedic ASA’s acquisition of Sensidose AB, the nomination committee recommends that Åsa Kornfeld, previous Board... |
| 26.05.2023 | Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer | Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer
Fri, May 26, 2023 08:00 CET Report this content
Oslo, 26 May 2023 – Following the closing of the acceptance period in the previously announc... |
| 11.05.2023 | Navamedic ASA Q1 2023: Another strong quarter | Navamedic ASA Q1 2023: Another strong quarter
Thu, May 11, 2023 08:00 CET Report this content
Oslo, 11 May 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies,... |
| 08.05.2023 | Navamedic ASA: Invitation to 2023 1st quarter presentation | Navamedic ASA: Invitation to 2023 1st quarter presentation
Mon, May 08, 2023 10:41 CET Report this content
Oslo, May 8, 2023 - Navamedic ASA (OSE: Nava) will be presenting its first quarter 2023 results on Thursday May 11, 2023. The present... |
| 28.04.2023 | Navamedic ASA: Annual Report for 2022 | Navamedic ASA: Annual Report for 2022
Fri, Apr 28, 2023 13:20 CET Report this content
Oslo, 28 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, annou... |
| 25.04.2023 | Navamedic ASA expands its offer to include warrants of series TO 1 issued by Sensidose Aktiebolag at a price of SEK 0.38 in cash per warrant of series TO 1 | Navamedic ASA expands its offer to include warrants of series TO 1 issued by Sensidose Aktiebolag at a price of SEK 0.38 in cash per warrant of series TO 1
Tue, Apr 25, 2023 22:10 CET Report this content
This announcement is not an offer, w... |
| 22.04.2023 | Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB | Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
Sat, Apr 22, 2023 13:10 CET Report this content
Oslo, 22 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of hig... |
| 22.04.2023 | Navamedic completes the offer, has entered into agreements to acquire approximately 56.7 per cent of the shares in Sensidose and increases the consideration to SEK 8 in cash per share | Navamedic completes the offer, has entered into agreements to acquire approximately 56.7 per cent of the shares in Sensidose and increases the consideration to SEK 8 in cash per share
Sat, Apr 22, 2023 13:00 CET Report this content
This ann... |
| 29.03.2023 | Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million | Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
Wed, Mar 29, 2023 07:31 CET Report this content
Oslo, 29 March 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-qualit... |
| 16.02.2023 | Navamedic ASA: Q4 2022 financial results | Navamedic ASA: Q4 2022 financial results
Thu, Feb 16, 2023 08:00 CET Report this content
Oslo, 16 February 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies,... |
| 13.02.2023 | Navamedic ASA: Invitation to 2022 4th quarter presentation | Navamedic ASA: Invitation to 2022 4th quarter presentation
Mon, Feb 13, 2023 09:00 CET Report this content
Oslo, February 13, 2023 - Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2022 results on Thursday February 16, 2023.... |
| 04.08.2022 | Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® | Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®
Thu, Aug 04, 2022 14:09 CET Report this content
Oslo, 4 August 2022 - Navamedic has signed an agreement with the French pharmaceutic... |
| 10.05.2022 | Navamedic ASA: Q1 2022 financial results | Navamedic ASA: Q1 2022 financial results
Tue, May 10, 2022 08:00 CET Report this content
Oslo, 10 May 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and
reliable provider of high-quality products to hospitals and pharmacies, grew... |
| 01.06.2021 | Navamedic ASA: Launch of new products strengthen the category of Medical Nutrition | Navamedic ASA: Launch of new products strengthen the category of Medical Nutrition Tue, Jun 01, 2021 09:51 CET
Oslo June 1th, 2021 – Navamedic ASA (“Navamedic”, OSE: NAVA) announces the launch of new products in the Nordics.
Medical Nutriti... |
| 20.05.2021 | Obesity patient support program launched in Norway | Obesity patient support program launched in Norway Thu, May 20, 2021 11:53 CET
Today Navamedic launches MyControl Support in Norway, a free-of-charge patient support program in collaboration with Observia, following a successful launch in S... |
